Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to demonstrate that the use of Gleevec in initially non-resectable
gastrointestinal stromal tumors can lead to allow complete resection in 20% of cases.